3 Firms Guide Drug Co. Sartorius' €2.4B Bid For Polyplus
Drug developer and manufacturer Sartorius Stedim Biotech, which is guided by Milbank LLP, said Friday that it will acquire Polyplus, a French producer of cell and gene therapies, which is being...To view the full article, register now.
Already a subscriber? Click here to view full article